Abstract：Objective To explore the influence of LPS on SPLUNC1 in Hela cells and A549 cells.Methods The two cell lines were cultured and divided into the control group and experimental group randomly. CCK-8 was used to study the time-response and dose-response relationship between LPS and proliferation and to screen the optimal concentration and action time of LPS in each cell line. After treatment with the optimal concentration and action time of LPS, the relative expression of SPLUNC1 was measured by immunohistochemical staining and immunofluorescence assay.Results The optimal concentration of LPS for A549 cells was 20 mg/L, and the optimal action time was 12 h. For Hela cells, the values were 40 mg/l and 12-24 h respectively. Both A549 cells and Hela cells expressed SPLUNC1. After LPS exposure,the expression of SPLUNC1 was up-regulated significantly(P＜0.05).Comparison between the two cell lines showed that after treatment with LPS the relative expression of SPLUNC1 in Hela cells was significantly higher than in A549 cells (P＜0.05), and the increment(Δ) of SPLUNC1 compared to the control in Hela cells was also significantly greater than in A549 cells(P＜0.05).Conclusions SPLUNC1 is expressed in cervical cancer. It can be a protective cell agent against lung adenocarcinoma and cervical cancer with potential clinical value.
曹留霞, 武涧松, 陈洁. LPS对A549和Hela细胞SPLUNC1蛋白表达的影响[J]. 武警医学, 2019, 30(9): 752-755.
CAO Liuxia, WU Jiansong, CHEN Jie. The influence of LPS on the expression of SPLUNC1 in Hela cells and A549 cells. Med. J. Chin. Peop. Armed Poli. Forc., 2019, 30(9): 752-755.
Chen P, Guo X, Zhou H, et al. SPLUNC1 regulates cell progression and apoptosis through the miR-141-PTEN/p27 pathway, but is Hindered by LMP1[J]. PLoS One, 2013, 8 (3): e56929.
Sayeed S, Nistico L, St Croix C, et al. Multifunctional role of human SPLUNC1 in pseudomonas aeruginosa infection [J]. Infect Immun, 2013, 81(1):285-291.
[4]
Liu Y, Bartlett J A , Di M E, et al. SPLUNC1/BPIFA1 contributes to pulmonary host defense against Klebsiella pneumoniae respiratory infection[J]. Am J Pathol, 2013, 182(5):1519-1531.
[5]
Teeguarden J G, Webb-Robertson B J, Waters K M, et al. Comparative proteomics and pulmonary toxicity of instilled singlewalled carbon nanotubes, crocidolite asbestos, and ultrafine carbon black in mice[J]. Toxicol Sci, 2011, 120(1): 123-135.
[6]
Liu H, Zhang X,Wu J, et al. New insights on the palate, lung, and nasal epithelium clone (PLUNC) proteins: based on molecular and functional analysis of its homolog of YH1/SPLUNC1[J]. Exp Mol Pathol, 2016, 100(3):363-369.
[7]
Chen W, Zheng R, Baade P D, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66 (2):115-132.
[8]
Crafton S M, Salani R. Beyond chemotherapy: an overview and review of targeted therapy in cervical cancer [J]. Clin Ther, 2016, 38(3):449-458.
[9]
Pesic M, Greten F R. Inflammation and cancer: tissue regeneration gone awry[J]. Curr Opin Cell Biol, 2016, 43:55-61.
[10]
Fernandes J V, Cobucci R N,Jatoba C A , et al. The role of the mediators of Iinflammation in cancer development[J]. Pathol Oncol Res, 2015, 21(3):527-534.
[11]
Solinas G, Marchesi F, Garlanda C, et al. Inflammation-mediated promotion of invasion and metastasis [J]. Cancer Metastasis Rev, 2010, 29(2):243-248.
[12]
Aggarwal B B, Sung B, Gupta S C. Advances in experimental medicine and biology[M]// Comes M , Teixeira AL, Coelho A, et al. The role of inflammation in lung cancer. Berlin: Springer Basel, 2014:1-23.
Zhang L, Deng T, Li X, et al. MicroRNA-141 is involved in a nasopharyngeal carcinoma-related genes network[J]. Carcinogenesis, 2010, 3l(4):559-566.
[17]
Benlloch S, Galbis-Caravajal J M, Alenda C, et al. Expression of molecular markers in mediastinal nodes from resected stageI non-small-cell lung cancer(NSCLC): prognostic impact and potential role as markers of occult micrometastases[J]. Ann Oncol, 2009, 20(1):91-97.
[18]
Britto C J, Liu Q, Curran D R, et al. Short palate, lung, and nasal epithelial clone-1 is a tightly regulated airway sensor in innate and adaptive immunity[J]. Am J Respir Cell Mol Biol, 2013, 48(6): 717-724.
[19]
Gakhar L, Bartlett J A, Penterman J, et al. PLUNC is a novel airway surfactant protein with anti-biofilm activity[J]. PLoS One, 2010, 5(2):e9098.
[20]
Wei Y, Xia W, Ye X, et al. The antimicrobial protein short palate, lung, and nasal epithelium clone 1 (SPLUNC1) is differentially modulated in eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps[J]. J Allergy Clin Immunol, 2014, 133(2):420-428.
[21]
Musa M, Wilson K, Sun L, et al. Differential localisation of BPIFA1 (SPLUNC1) and BPIFB1 (SPLUNC1) in the nasal and oral cavities of mice[J]. Cell Tissue Res, 2012, 350 (3):455-464.
2019, Vol. 30 
